Financial News
Latest News about KTTA
Recent news which mentions KTTA
From InvestorPlace
24 Stocks Moving in Thursday's Pre-Market Session
November 18, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 17, 2021
From Benzinga
EXCLUSIVE: Pasithea Clinics Launches In-Home Intravenous Ketamine Therapy In Major US Cities
November 17, 2021
Tickers
KTTA
From Benzinga
This Company Wants To Deliver Better Mental Health Straight to Your Door
November 10, 2021
From Benzinga
Knock, Knock: It's 2021, and Mental Health Is at Your Door
November 05, 2021
Tickers
KTTA
From Benzinga
64 Biggest Movers From Yesterday
November 02, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 01, 2021
From Benzinga
Pasithea and Evotec Team Up — Attempt to Make Headway on Brain Disorders
November 01, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 28, 2021
From Benzinga
From InvestorPlace
30 Stocks Moving in Thursday's Pre-Market Session
October 28, 2021
From Benzinga
Biotech Companies Are Embracing the Growing Psychedelic Drug Market To Confront a Global Increase in Depression and Anxiety
October 27, 2021
From Benzinga
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy
October 27, 2021
Tickers
KTTA
From Benzinga
EXCLUSIVE: Pasithea Administers First IV Ketamine Infusion Therapy In Depression Patients
October 27, 2021
Tickers
KTTA
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
This Company Just Extended its Reach into the United Kingdom by Opening its First Ketamine Therapy Clinic
October 18, 2021
From Benzinga
Pasithea Therapeutics Opens its First Ketamine Therapy Clinic in the United Kingdom
October 14, 2021
Tickers
KTTA
From Benzinga
From Benzinga
Biotech Company Pasithea Therapeutics Teams Up With Evotec to Aid Mental Health Drug Discovery
October 11, 2021
From Benzinga
Pasithea, Evotec Ink Drug Development Pact
October 11, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
